Symrise AG SYIEY

MaterialsChemicalsGermany

Last close 25.91 USD on Nov 1, 2026, +31.0% year to date

Quant rating

Quant rating C Rank 137 of 220 in Materials

Growth C 132 of 220
Valuation C 129 of 220
Quality D 181 of 220
Revisions C 150 of 220
Momentum B 43 of 220

Wall Street consensus Strong Buy (1.00)Average target 32.00 USD +23.5%

Historical valuation

Multiples use consensus estimates for the next twelve months. The dashed line is the 5-year average.

Key data

Market cap: 14.5B
Enterprise value: 16.6B
52-week range: 19.31 – 28.77
3-year range: 19.31 – 34.50
Dividend yield: 1.42%
Beta (5 years): 0.62
Shares outstanding: 140M
Next earnings: Oct 30, 2026

About the company

Symrise AG is a Germany-based company. The Company is engaged as a supplier of fragrances, flavorings, cosmetic active ingredients and raw materials, functional ingredients and product solutions for food production based on natural base materials. The Company operates through two segments: Taste, Nutrition & Health and Scent & Care segment. The Taste, Nutrition & Health segment includes the Food & Beverage and Pet Food divisions as well as the two smaller units Aqua Feed and Probi. It uses scientific research to offer customers and partners solutions in the areas of taste, nutrition and health that are sustainable and based on natural ingredients. The Company develops specific active solutions for the desired health benefits. The Scent & Care segment includes the Fragrance, Cosmetic Ingredients and Aroma Molecules divisions. The Fragrance division combine aromatic raw materials like aroma chemicals and essential oils to make complex fragrances (perfume oils).

Growth and profitability fiscal year ends December 31

Growth and profitability by fiscal year
	2025	2024	2023	2022	2021	5Y avg
Revenue (mil)	5,789	5,175	5,220	4,943	4,349	–
Revenue growth	11.9%	−0.9%	5.6%	13.7%	1.2%	6.1%
EPS (basic, normalized)	1.04	0.93	0.69	0.77	–	–
EPS growth	12.2%	33.1%	−9.4%	–	–	–
Gross margin	37.6%	39.3%	35.8%	36.9%	38.7%	37.6%
Net margin	5.1%	9.6%	7.2%	6.1%	9.9%	7.6%
ROE	6.5%	12.6%	9.5%	8.3%	13.7%	10.1%

Balance sheet, last quarter
Cash & short-term investments (mil)	–
Current ratio	–
Long-term debt (mil)	–
Net debt (mil)	–
Total equity (mil)	–
Net debt / equity	–
Net debt / EBITDA	–

Estimates and valuation

Consensus estimates and implied multiples
	Sales (mil)			EBITDA (mil)			EPS
Fiscal year	Mean est.	Growth	EV/Sales	Mean est.	Growth	EV/EBITDA	Mean est.	Growth	P/E
2025 actual	5,789	+11.9%	2.9x	1,033	−1.8%	16.1x	1.04	+12.2%	25.0x
2026	5,724	−1.1%	2.9x	1,251	+21.1%	13.3x	1.16	+11.8%	22.3x
2027	5,938	+3.7%	2.8x	1,334	+6.6%	12.4x	1.34	+15.5%	19.3x

Estimate revisions

Change in consensus estimates over 1, 3 and 6 months
	Sales				EPS
Fiscal year	Estimate (mil)	1M	3M	6M	Estimate	1M	3M	6M
2026	5,724	0.0%	+2.3%	+0.9%	1.16	0.0%	+0.9%	0.0%
2027	5,938	0.0%	+1.5%	+0.2%	1.34	0.0%	+3.1%	+2.3%
2028	–	–	–	–	–	–	–	–

Earnings surprises

Reported results versus consensus, last 10 fiscal quarters
	FQ-9	FQ-8	FQ-7	FQ-6	FQ-5	FQ-4	FQ-3	FQ-2	FQ-1	FQ0
Sales reported (mil)	–	–	–	–	–	–	–	–	–	–
Sales mean (mil)	–	–	–	–	–	–	–	–	–	–
Surprise	–	–	–	–	–	–	–	–	–	–
EPS reported	–	–	–	–	–	–	–	–	–	–
EPS mean	–	–	–	–	–	–	–	–	–	–
Surprise	–	–	–	–	–	–	–	–	–	–

FQ0 is the most recent reported quarter, FQ-1 the one before, and so on.

Peer comparison Chemicals

Peers in the same industry group, by market capitalization
Company	Market cap	Net debt/EBITDA	Net margin	P/B	FY1 P/E	FY2 P/E	FY1 EV/EBITDA	FY2 EV/EBITDA
SYIEY Symrise AG	14.5B	–	5.1%	3.42x	22.3x	19.3x	13.3x	12.4x
NNUP Nocopi Technologies, Inc.	19M	–	−10.4%	1.30x	−40.0x	14.5x	–	–
Mean		–	−2.7%	2.36x	−8.8x	16.9x	13.3x	12.4x
Median		–	−2.7%	2.36x	−8.8x	16.9x	13.3x	12.4x

Technical analysis

1M−2.3%
3M+2.0%
1Y+18.4%
3Y+7.9%

Financial statements in millions of USD

Income statement in millions of USD, fiscal years

Income statement, Symrise AG, fiscal years, most recent first
	2025	2024	2023	2022	2021	2020
Total revenue	5,789	5,175	5,220	4,943	4,349	4,300
Cost of revenue	3,611	3,142	3,352	3,121	2,668	2,601
Gross profit	2,178	2,033	1,868	1,822	1,681	1,698
Selling, general & administrative expenses	1,167	1,033	1,050	1,004	892	900
Research & development	324	285	293	272	251	259
Interest expense (income), operating	−6.8	−6.0	−10.2	−13.8	−5.4	−4.3
Unusual expense (income)	176	–	0	116	9.4	–
Other operating expenses	−28.7	−23.1	−82.6	−96.3	−101	−51.9
Operating income	546	743	617	539	635	595
Net interest income (expense)	−44.6	−52.6	−67.1	−59.7	−35.4	−49.5
Gain (loss) on sale of assets	–	–	–	–	–	–
Other non-operating income (expense)	−33.9	−22.0	−37.1	−18.3	−13.2	−28.6
Net income before taxes	468	669	513	461	587	517
Provision for taxes	170	170	132	150	149	133
Minority interest	−5.0	−3.9	−4.9	−11.4	−11.5	−9.9
Equity in affiliates	–	–	–	–	–	–
U.S. GAAP adjustment	–	–	–	–	–	–
Net income before extraordinary items	293	495	376	300	426	375
Extraordinary items	–	–	–	–	–	–
Net income	293	495	376	300	426	375
EBIT, normalized	1,075	758	612	642	639	591
EBITDA, normalized	1,423	1,051	931	953	953	902
Basic EPS, normalized	1.04	0.93	0.69	0.77	–	–

Balance sheet in millions of USD, fiscal years

Balance sheet, Symrise AG, fiscal years, most recent first
	2025	2024	2023	2022	2021	2020
Assets
Cash & short-term investments	1,186	735	434	337	516	904
Receivables	1,298	1,108	1,116	1,058	965	753
Total inventory	1,256	1,329	1,386	1,421	1,125	1,054
Prepaid expenses	–	–	–	–	–	–
Other current assets	145	44.5	46.4	56.8	44.5	97.5
Total current assets	3,885	3,216	2,982	2,872	2,651	2,809
Property, plant & equipment	1,817	1,812	1,842	1,676	1,505	1,472
Goodwill	2,127	1,984	2,078	2,036	1,822	1,688
Intangibles	790	843	982	1,068	1,029	992
Long-term investments	503	639	643	558	130	119
Note receivable	–	–	–	–	–	–
Other long-term assets	161	125	132	120	449	175
Total assets	9,283	8,619	8,658	8,329	7,586	7,254
Liabilities
Accounts payable	497	522	540	567	469	408
Payable/accrued	–	–	–	–	–	–
Accrued expenses	20.9	13.9	15.8	14.9	7.4	179
Short-term debt	0	0	0	0	0	0
Current portion of long-term debt	490	915	53.6	43.1	420	30.3
Other current liabilities	532	542	424	415	406	185
Total current liabilities	1,540	1,993	1,034	1,040	1,302	802
Long-term debt	2,578	1,707	2,754	2,668	1,620	2,492
Minority interest	26.4	39.8	60.6	63.2	73.2	73.0
Other liabilities	770	757	802	758	966	1,075
Total liabilities	4,914	4,497	4,651	4,529	3,962	4,443
Shareholders' equity
Preferred stock	–	–	–	–	–	–
Common stock	164	145	154	150	159	165
Additional paid-in capital	2,561	2,258	2,407	2,334	2,479	2,196
Retained earnings (accumulated deficit)	2,258	1,925	1,747	1,488	1,510	1,284
Treasury stock	–	–	–	–	–	–
Other equity	−614	−205	−300	−171	−524	−834
Total equity	4,369	4,122	4,007	3,801	3,624	2,811
Total liabilities & shareholders' equity	9,283	8,619	8,658	8,329	7,586	7,254

Cash flow statement in millions of USD, fiscal years

Cash flow statement, Symrise AG, fiscal years, most recent first
	2025	2024	2023	2022	2021	2020
Operating activities
Net income	298	499	381	311	438	385
Depreciation, depletion & amortization	354	327	323	312	290	311
Deferred taxes	–	–	–	–	–	–
Non-cash items	570	268	247	311	166	207
Changes in working capital	−318	−174	−174	−562	−307	−130
Cash from operations	903	921	777	372	587	773
Investing activities
Capital expenditures	−248	−251	−298	−268	−198	−176
Other investing cash flows	0.8	−50.4	−91.1	−786	−613	−6.9
Cash from investing	−247	−302	−389	−1,054	−811	−183
Financing activities
Financing cash flow items	−187	−81.6	−81.9	−66.9	−47.2	−55.6
Cash dividends paid	−197	−159	−162	−153	−149	−157
Issuance (retirement) of debt, net	–	–	–	–	–	–
Other financing cash flows	111	−51.1	−53.9	735	91.8	−17.8
Cash from financing	−273	−292	−298	515	−105	−231
Foreign exchange effects	−30.3	0.9	−3.3	17.7	20.8	−18.5
Net change in cash	352	328	86.3	−149	−308	341
Free cash flow	655	669	478	105	389	597

Disclaimer

The financial data presented in this report is delayed and obtained from sources QDD Research believes to be reliable, including stock exchanges, SEDAR, and EDGAR. However, no representation or warranty is made as to the accuracy, completeness, or timeliness of the information. QDD Research accepts no liability for any errors, omissions, or financial losses arising from the use of this data.

This report is generated using a fully systematic and quantitative approach. All factor scores and the overall quant rating (ranging from D to A+) are derived from algorithmic models and are based solely on objective financial metrics. These scores are intended for informational purposes only and should not be interpreted as investment advice or a recommendation to buy, sell, or hold any securities.

QDD Research is not a registered investment advisor or broker-dealer and does not provide personalized financial advice. The content is not tailored to the specific investment goals, financial situation, or risk profile of any individual investor. We strongly encourage readers to consult with a licensed broker or investment advisor before making any investment decisions based on the information contained in this report.

Live quote provided by TradingView. Report data updated Nov 1, 2026 after market close.